PFG Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

PFG Advisors’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$230K	Hold	2,364	–	–	0.01%	700
2026 Q2	$212K	Buy	+2,364	New	+$195K	0.01%	764
2022 Q3	–	Sell	-3,469	Closed	-$200K	–	539
2022 Q2	$200K	Sell	3,469 -38	-1%	-$2.19K	0.02%	369
2022 Q1	$218K	Sell	3,507 -19,412	-85%	-$1.18M	0.02%	383
2021 Q4	$1.63M	Sell	22,919 -8,828	-28%	-$639K	0.16%	181
2021 Q3	$2.38M	Sell	31,747 -80	-0.3%	-$6.1K	0.26%	109
2021 Q2	$2.46M	Buy	31,827 +920	+3%	+$68.4K	0.28%	99
2021 Q1	$2.28M	Buy	30,907 +440	+1%	+$33.3K	0.29%	101
2020 Q4	$2.14M	Buy	30,467 +100	+0.3%	+$6.33K	0.36%	75
2020 Q3	$1.83M	Buy	30,367 +147	+0.5%	+$8.64K	0.35%	79
2020 Q2	$1.81M	Buy	30,220 +140	+0.5%	+$7.63K	0.41%	76
2020 Q1	$1.59M	Sell	30,080 -90	-0.3%	-$4.69K	0.43%	75
2019 Q4	$1.66M	Sell	30,170 -225	-0.7%	-$11.7K	0.41%	77
2019 Q3	$1.41M	Buy	30,395 +3	+0%	+$154	0.39%	72
2019 Q2	$1.6M	Buy	30,392 +232	+0.8%	+$12K	0.43%	61
2019 Q1	$1.57M	Sell	30,160 -795	-3%	-$42K	0.48%	55
2018 Q4	$1.6M	Buy	+30,955	New	+$1.59M	0.5%	56

Other funds holding PBE

YHB Investment Advisors West Hartford, Connecticut $1.59B AUM 21.04% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Archford Capital Strategies Swansea, Illinois $1.01B AUM 23.17% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return

Dynamic Advisor Solutions Phoenix, Arizona $3.52B AUM 15.33% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

Allen Mooney & Barnes Investment Advisors Thomasville, Georgia $673M AUM 20.03% 1-Year Est. Return

First PREMIER Bank Sioux Falls, South Dakota $621M AUM 13.03% 1-Year Est. Return

PFG Advisors's PBE Position: Q3 2026 in Review

PFG Advisors held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q3 2026 at 2,364 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #700.

PFG Advisors first reported a position in PBE in Q4 2018 and has held it in 17 quarters since. The position peaked at $2.46M in Q2 2021. 15 funds tracked by Wall St. Rank hold PBE as of Q3 2026.

PFG Advisors held 2,364 shares of Invesco Biotechnology & Genome ETF worth $230K as of Q3 2026.
PFG Advisors left its Invesco Biotechnology & Genome ETF share count unchanged in Q3 2026.
Invesco Biotechnology & Genome ETF made up 0.01% of PFG Advisors's portfolio in Q3 2026, its #700 holding.
PFG Advisors first reported a position in Invesco Biotechnology & Genome ETF in Q4 2018 and has held it in 17 quarters since.
PFG Advisors's Invesco Biotechnology & Genome ETF position peaked at $2.46M in Q2 2021.
15 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.

Based on PFG Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.